ACI's European Prefilled Syringes Summit will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation, portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes.
There are several elements that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs.
Other more traditional factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and needle stick prevention.
Dirk Kreder (CEO anteris medical) has given a speech on Sep 19th under the topic: "Quality and Compliance for Prefilled Syringes and Autoinjectors: Why Adherence to Combination Product Regulations is a Good Idea"
Looking forward to next year.